New male contraceptive device aims to be reversible

NCT ID NCT07361120

Recruiting now Disease control Sponsor: Next Life Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new device called Plan A that blocks sperm from passing through the vas deferens, similar to a vasectomy, but designed to be reversed later. Forty healthy men aged 25 to 65 will receive the device and be monitored for safety and effectiveness. The goal is to see if it can reliably prevent pregnancy and then be reversed to restore fertility.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Plan A Male Contraceptive System (a device that blocks the vas deferens)
What this could lead to: If successful, this could provide a long-term, reversible male contraceptive option similar to a vasectomy but designed to be reversed.
What could go wrong: This is a small, early-phase trial with only 40 participants. The device may not reliably block sperm or be safely reversible, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder male infertility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FERTILITY FERTILITY, MALE HEALTHY MALE ADULTS

Contacts and locations

Locations

Western Urology
RECRUITING

Maribyrnong, Victoria, 3032, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.